Can you name a vaccine currently on the market which has not undergone testing in a study with a randomized, double-blind placebo-controlled design? I am not sure why RFK Jr.’s belief on the subject should be taken seriously.
The current establishment position is that it’s unethical to run randomized, double-blind placebo-controlled trials for vaccines if there’s already an existing vaccine on the market that targets a given illness. Instead, new vaccines for illnesses with existing vaccines get tested against an existing vaccine. In practice, most of the commonly used childhood vaccines in the United States fall under that category.
Those are just the basic facts of the issue whether or not you like RFK Jr. The more interesting question is about whether his policy demand of requiring randomized, double-blind placebo-controlled trials for each vaccine is one that should be adopted or not. And if it gets adopted what happens with existing vaccines that fail that standard.
Saying “whatever ways are reasonable” is ignoring the key issues.
Robert F. Kennedy Jr. believes that all vaccines should require placebo-blind trials to be licensed the most other drugs do.
Whether or not that’s reasonable is the key question.
Do you believe that Medicaid/Medicare should just pay the sticker price for everyone who wants it?
Can you name a vaccine currently on the market which has not undergone testing in a study with a randomized, double-blind placebo-controlled design? I am not sure why RFK Jr.’s belief on the subject should be taken seriously.
The current establishment position is that it’s unethical to run randomized, double-blind placebo-controlled trials for vaccines if there’s already an existing vaccine on the market that targets a given illness. Instead, new vaccines for illnesses with existing vaccines get tested against an existing vaccine. In practice, most of the commonly used childhood vaccines in the United States fall under that category.
Those are just the basic facts of the issue whether or not you like RFK Jr. The more interesting question is about whether his policy demand of requiring randomized, double-blind placebo-controlled trials for each vaccine is one that should be adopted or not. And if it gets adopted what happens with existing vaccines that fail that standard.